WCN26-3952 The Impact of SGLT2 Inhibitors on the Pathophysiology of Polycystic Kidney Disease

Read full text Summarise with VIRAT
Authors: Shun Takenaka, Fumihiko Hattanda, Takuro Kawamura, Kanako Watanabe‐Kusunoki, Daigo Nakazawa, Tatsuya Atsumi, Saori Nishio
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The pathogenesis of ADPKD involves multiple factors, such as cystic epithelial cell proliferation and apoptosis, fibrosis, mitochondrial dysfunction, and cyst fluid accumulation. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to improve renal outcomes in chronic kidney disease; however, their effects on ADPKD remain unclear. In this study, we investigated the effects of SGLT2 inhibitors on renal cyst progression and analyzed their underlying mechanisms using ADPKD model mice.

Fields of Study & Subjects

Genetic and Kidney Cyst Diseases Chronic Kidney Disease and Diabetes Tuberous Sclerosis Complex Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105111–105111
Publication date
25 March 2026
Language
EN